keyword
https://read.qxmd.com/read/38614885/ser-recommendations-on-treatment-of-refractory-beh%C3%A3-et-s-syndrome
#21
JOURNAL ARTICLE
Clara Moriano Morales, Jenaro Graña Gil, Noé Brito García, José Luis Martín Varillas, Vanesa Calvo Del Río, Patricia Moya Alvarado, Francisco Javier Narváez García, Gerard Espinosa, Petra Díaz Del Campo Fontecha, Mercedes Guerra Rodríguez, José Mateo Arranz, Manuela López Gómez, Félix Manuel Francisco Hernández, M Mar Trujillo, Raquel Dos Santos Sobrín, Juan Ignacio Martín Sánchez, Jesús Maese Manzano, Julio Suárez Cuba
OBJECTIVE: To develop multidisciplinary recommendations based on available evidence and expert consensus for the therapeutic management of patients with refractory Behçet's syndrome (BS) (difficult to treat, severe resistant, severe relapse) to conventional treatment. METHODS: A group of experts identified clinical research questions relevant to the objective of the document. These questions were reformulated in PICO format (patient, intervention, comparison and outcome)...
April 12, 2024: Reumatología clinica
https://read.qxmd.com/read/38614842/developing-a-core-outcome-set-for-evaluating-medication-adherence-interventions-for-adults-prescribed-long-term-medication-in-primary-care
#22
JOURNAL ARTICLE
Debi Bhattacharya, Kumud Kantilal, Jacqueline Martin-Kerry, Vanessa Millar, Allan Clark, David Wright, Katherine Murphy, David Turner, Sion Scott
BACKGROUND: Approximately half of people prescribed medications do not take them as prescribed. There is a significant unmet need regarding the barriers to medication adherence not being addressed in primary care. There is no agreement on which outcomes should be measured and reported in trials of medication adherence interventions. OBJECTIVE: To develop a core outcome set (COS) for trials of medication adherence interventions in primary care for adults prescribed medications for long-term health conditions...
April 3, 2024: Research in Social & Administrative Pharmacy: RSAP
https://read.qxmd.com/read/38614829/recent-advances-in-plant-based-bioproduction
#23
REVIEW
Kazuhito Fujiyama, Toshiya Muranaka, Atsushi Okazawa, Hikaru Seki, Goro Taguchi, Shuhei Yasumoto
Unable to move on their own, plants have acquired the ability to produce a wide variety of low molecular weight compounds to survive against various stresses. It is estimated that there are as many as one million different kinds. Plants also have the ability to accumulate high levels of proteins. Although plant-based bioproduction has traditionally relied on classical tissue culture methods, the attraction of bioproduction by plants is increasing with the development of omics and bioinformatics and other various technologies, as well as synthetic biology...
April 13, 2024: Journal of Bioscience and Bioengineering
https://read.qxmd.com/read/38614815/direct-in-vivo-car-t-cell-engineering
#24
REVIEW
Lauralie Short, Robert A Holt, Pieter R Cullis, Laura Evgin
T cells modified to express intelligently designed chimeric antigen receptors (CARs) are exceptionally powerful therapeutic agents for relapsed and refractory blood cancers and have the potential to revolutionize therapy for many other diseases. To circumvent the complexity and cost associated with broad-scale implementation of ex vivo manufactured adoptive cell therapy products, alternative strategies to generate CAR T cells in vivo by direct infusion of nanoparticle-formulated nucleic acids or engineered viral vectors under development have received a great deal of attention in the past few years...
April 12, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38614808/four-key-problems-that-will-need-to-be-addressed-during-the-next-pandemic
#25
JOURNAL ARTICLE
Daniel Pan, Julian W Tang
In June 2023, the UK began official hearings for its independent investigation into pandemic preparedness. Thus far, the inquiry has been told that planning has been wholly inadequate and that a future outbreak is inevitable. We present here four key problems that contributed to significant morbidity and mortality during the Coronavirus 2019 (COVID-19) pandemic over the past 3 years in the UK - and which will contribute to excess morbidity and mortality in the next outbreak. First, there was misunderstanding about what procedures were deemed as aerosol generating...
September 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614800/sars-cov-2-vaccines-and-myocarditis
#26
REVIEW
Agata Katarzyna Sularz, Alina Hua, Tevfik Ismail
The development of safe and effective vaccines against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) was a major turning point in the fight against the Coronavirus 2019 (COVID-19) pandemic. However, pharmacovigilance has revealed a small but significant incidence of cardiac inflammation manifesting clinically as myocarditis or pericarditis, particularly in younger vaccine recipients. The incidence is the highest among men under age 40 within a week of receiving the second dose of the mRNA vaccine...
September 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614791/updates-in-heart-failure
#27
REVIEW
Oliver L Rees, Peter Wheen, Lisa J Anderson
This review provides a contemporary overview of HF management and highlights the key studies which have informed recent European HF guidelines.
September 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614647/future-therapies-for-obesity
#28
REVIEW
Eka Melson, Alexander Dimitri Miras, Dimitris Papamargaritis
Obesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not scalable at the population level. Over the past few years, gut hormone-based pharmacotherapies for obesity and type 2 diabetes mellitus (T2DM) have rapidly evolved, and combinations of glucagon-like peptide 1 (GLP1) with other gut hormones (glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) as dual or triple agonists are under investigation to enhance and complement the effects of GLP1 on WL and obesity-related complications...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614645/medical-management-of-obesity
#29
JOURNAL ARTICLE
Sheena Gupta, Mimi Chen
Obesity is a global epidemic that has worsened over the past few decades. It is strongly associated with multiple health conditions, including type 2 diabetes mellitus, cardiovascular diseases, obstructive sleep apnoea, certain malignancies and has an increased mortality risk. The annual cost of obesity to the NHS is around £6 billion, projected to increase to just under £10 billion by 2050. In 2020-2021, obesity was cited as a factor in over 1 million hospital admissions. An early and pragmatic approach to the management of obesity would reduce obesity-associated multiple health conditions and result in cost savings for the NHS...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614536/the-teaching-of-radiology-in-other-university-studies
#30
JOURNAL ARTICLE
M Alcaraz Baños, A Olivares, J A García Gamuz, J D Berná Mestre, J L Navarro Fernández
After the implementation of the European Space for Higher Education, the contents of the Radiology and Physical Medicine Area that were taught in the Medicine Degree have also been incorporated into the new degrees of Dentistry, Nursing, Physiotherapy, Podiatry, and, to a lesser extent, Pharmacy, Occupational Therapy, Logopedia, and Biomedical Engineering As a whole, the basic concepts of radiology and radiological protection are taught in Murcia in 5 different degrees with a total of 52.5 ECTS credits, participating in the training of 1219 students each academic year...
2024: Radiología
https://read.qxmd.com/read/38614434/formulation-study-of-plga-in-situ-films-for-topical-delivery-of-salicylates
#31
JOURNAL ARTICLE
Eva Snejdrova, Jan Loskot, Andrea Veris, Petr Kastner, Rudolf Andrys
A film-forming system (FFS) represents a convenient topical dosage form for drug delivery. In this study, a non-commercial poly(lactic-co-glycolic acid) (PLGA) was chosen to formulate an FFS containing salicylic acid (SA) and methyl salicylate (MS). This unique combination is advantageous from a therapeutic point of view, as it enabled modified salicylate release. It is beneficial from a technological perspective too, because it improved thermal, rheological, and adhesive properties of the in situ film. DSC revealed complete dissolution of SA and good miscibility of MS with the polymer...
April 11, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38614433/gonadal-hormone-deprivation-regulates-response-to-tibolone-in-neurodegenerative-pathways
#32
JOURNAL ARTICLE
Andrew J McGovern, Maria Angeles Arevalo, Sergio Ciordia, Luis Miguel Garcia-Segura, George E Barreto
Gonadal hormone deprivation (GHD) and decline such as menopause and bilateral oophorectomy are associated with an increased risk of neurodegeneration. Yet, hormone therapies (HTs) show varying efficacy, influenced by factors such as sex, drug type, and timing of treatment relative to hormone decline. We hypothesize that the molecular environment of the brain undergoes a transition following GHD, impacting the effectiveness of HTs. Using a GHD model in mice treated with Tibolone, we conducted proteomic analysis and identified a reprogrammed response to Tibolone, a compound that stimulates estrogenic, progestogenic, and androgenic pathways...
April 11, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38614431/insights-of-biopolymeric-blended-formulations-for-diabetic-wound-healing
#33
REVIEW
Ameya Sharma, Divya Dheer, Vivek Puri, Abdulrhman Alsayari, Shadma Wahab, Prashant Kesharwani
Diabetic wounds (DWs) pose a significant health burden worldwide, with their management presenting numerous challenges. Biopolymeric formulations have recently gained attention as promising therapeutic approaches for diabetic wound healing. These formulations, composed of biocompatible and biodegradable polymers, offer unique properties such as controlled drug release, enhanced wound closure, and reduced scarring. In this review, we aim to provide a comprehensive overview of the current state of research and future prospects regarding the application of biopolymeric formulations for diabetic wound healing...
April 11, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38614430/a-strategy-for-oral-delivery-of-fgf21-for-mitigating-inflammation-and-multi-organ-damage-in-sepsis
#34
JOURNAL ARTICLE
Xinze Li, Dedong Yu, Xuanhe Chen, Zhiwei Huang, Yingzheng Zhao
Fibroblast growth factor 21 (FGF21) shows great therapeutic potential in metabolic, neurodegenerative and inflammatory diseases. However, current FGF21 administration predominantly relies on injection rather than oral ingestion due to its limited stability and activity post-gastrointestinal transit, thereby hindering its clinical utility. Milk-derived exosomes (mEx) have emerged as a promising vehicle for oral drug delivery due to their ability to maintain structural integrity in the gastrointestinal milieu...
April 11, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38614422/ketohexokinase-a-deficiency-attenuates-the-proliferation-via-reducing-%C3%AE-catenin-in-gastric-cancer-cells
#35
JOURNAL ARTICLE
Gang Ma, Siya Liu, Fenglin Cai, Han Liang, Jingyu Deng, Rupeng Zhang, Mingzhi Cai
Overconsumption of fructose is closely related to cancer. Ketohexokinase (KHK) catalyzes the conversion from fructose to fructose-1-phosphate (F1P), which is the first and committed step of fructose metabolism. Recently, aberrant KHK activation has been identified in multiple malignancies. However, the roles of KHK in gastric cancer (GC) cells are largely unclear. Herein, we reveal that the expression of ketohexokinase-A (KHK-A), one alternatively spliced KHK isoform that possesses low affinity for fructose, was markedly increased in GC cells...
April 11, 2024: Experimental Cell Research
https://read.qxmd.com/read/38614408/combining-fecal-16%C3%A2-s-rrna-sequencing-and-spinal-cord-metabolomics-analysis-to-explain-the-modulatory-effect-of-ppar%C3%AE-on-neuropathic-pain
#36
JOURNAL ARTICLE
Zi-Jun Wu, Yu-Ying Zhao, Shu-Jing Hao, Bei-Bei Dong, Yu-Xin Zheng, Bin Liu, Jing Li
BACKGROUND: Existing evidence suggests that the composition of the gut microbiota is associated with neuropathic pain (NP), but the mechanistic link is elusive. Peroxisome proliferator-activated receptor α (PPARα) has been shown to be a pharmacological target for the treatment of metabolic disorders, and its expression is also involved in inflammatory regulation. The aim of this study was to investigate the important modulatory effects of PPARα on gut microbiota and spinal cord metabolites in mice subjected to chronic constriction injury...
April 12, 2024: Brain Research Bulletin
https://read.qxmd.com/read/38614405/irpexols-a-c-xanthone-derivatives-from-the-endophyte-fungus-irpex-laceratus-a878
#37
JOURNAL ARTICLE
Yuchan Chen, Nuoyi Wang, Weipeng Ma, Wei Gu, Zihuan Sang, Haibo Tan, Weimin Zhang, Hongxin Liu
Three new xanthone derivatives irpexols A-C (1-3) and five known xanthones including three dimeric ones were successfully isolated from Irpex laceratus A878, an endophytic fungus of the family Irpicaceae from the medicinal plant Pogostemon cablin (Blanco) Bentham (Lamiaceae). The structures of these compounds were elucidated by extensive spectroscopic analyses includingultraviolet-visible spectroscopy (UV), infrared spectroscopy (IR), mass spectrometry (MS), and nuclear magnetic resonance (NMR). All of the three new compounds (1-3) share a de-aromatic and highly‑oxygenated xanthone skeleton...
April 11, 2024: Fitoterapia
https://read.qxmd.com/read/38614383/corosolic-acid-attenuates-platelet-derived-growth-factor-signaling-in-macrophages-and-smooth-muscle-cells-of-pulmonary-arterial-hypertension
#38
JOURNAL ARTICLE
Aya Yamamura, Moe Fujiwara, Akiko Kawade, Taiki Amano, Alamgir Hossain, Md Junayed Nayeem, Rubii Kondo, Yoshiaki Suzuki, Yasumichi Inoue, Hidetoshi Hayashi, Susumu Suzuki, Motohiko Sato, Hisao Yamamura
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease that is characterized by vascular remodeling of the pulmonary artery. Pulmonary vascular remodeling is primarily caused by the excessive proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), which are facilitated by perivascular inflammatory cells including macrophages. Corosolic acid (CRA) is a natural pentacyclic triterpenoid that exerts anti-inflammatory effects. In the present study, the effects of CRA on the viability of macrophages were examined using monocrotaline (MCT)-induced PAH rats and human monocyte-derived macrophages...
April 11, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38614382/proteasome-activation-is-critical-for-cell-death-induced-by-inhibitors-of-polo-like-kinase-1-plk1-in-multiple-cancers
#39
JOURNAL ARTICLE
Yufei Wang, Guihua Wang, Wei Xiang, Xueting Liu, Manli Jiang, Jinyue Hu
Inhibitors of polo-like kinase (PLK) are currently being evaluated as anticancer drugs. However, the molecular mechanism of PLK inhibitor-induced cell death is not fully understood. In this study, we found that GW843682X and BI2536, two inhibitors of PLK1, significantly induced cell death in multiple type cells. The induction of cell death was related to the preferring expression of PLK1. However, in human umbilical vascular endothelial cells (HUVEC) and human colorectal carcinoma cells, which expressed higher levels of both PLK1 and PLK2, PLK1 inhibitors induced very low levels of cell death...
April 11, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38614381/involvement-of-necroptotic-cell-death-in-macrophages-in-progression-of-bleomycin-and-lps-induced-acute-exacerbation-of-idiopathic-pulmonary-fibrosis
#40
JOURNAL ARTICLE
Atsushi Koike, Kaoruko Hayashi, Ko Fujimori
Idiopathic pulmonary fibrosis (IPF) is the severe form of interstitial pneumonias. Acute exacerbation (AE) of IPF is characterized by progressive lung fibrosis with the irreversible lung function decline and inflammation, and is often fatal with poor prognosis. However, the physiological and molecular mechanisms in AE of IPF are still not fully understood. In this study, we investigated the mechanism underlying AE of IPF, using bleomycin (BLM) and lipopolysaccharide (LPS) (BLM+LPS)-treated mice. The mice were treated with a single dose of 1...
April 11, 2024: European Journal of Pharmacology
keyword
keyword
166316
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.